CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

Clinical trial NCT04681131 · COMPLETED

Trial details

NCT number: NCT04681131
Sponsor: BioAtla, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer

Start date: 2021-03-17
Primary completion: 2025-07-09
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.